On a constant currency basis, net sales increased 5 percent during the second quarter of FY 2010. U.S. sales increased 8 percent during the quarter to $408.2 million and, excluding dental and the effect of foreign currency, net sales increased 7 percent worldwide and 9 percent in the United States, according to the release.
Reported operating income totaled $94.1 million during the second quarter of FY 2010 compared to $80.0 million for the second quarter of FY 2009.
Biomet recorded a net loss of $7.2 million, on a reported basis, during the second quarter of FY 2010 compared to a reported net loss of $39.7 million for the second quarter of FY 2009, according to the release. Excluding special items, adjusted net income totaled $74.8 million during the second quarter of FY 2010 compared to adjusted net income of $34.0 million for the same period in the prior fiscal year.
Read the release on Biomet’s second quarter results for FY 2010.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.